References
- Said AS, Manji KP. Risk factors and outcomes of fetal macrosomia in a tertiary centre in Tanzania: a case-control study. BMC Pregn Childbirth. 2016;16(1):243.
- Baka S, Malamitsi-Puchner A, Boutsikou T, et al. Cord blood irisin at the extremes of fetal growth. Metabolism. 2015;64(11):1515–1520.
- Dor N, Mosberg H, Stern W, et al. Complications in fetal macrosomia. NY State J Med. 1984;84(6):302–305.
- Zhang X, Decker A, Platt RW, et al. How big is too big? The perinatal consequences of fetal macrosomia. Am J Obstet Gynecol. 2008;198(5):517.e1–517.e6.
- Wang X, Liang L, Junfen FU, et al. Metabolic syndrome in obese children born large for gestational age. Indian J Pediatr. 2007;74(6):561–565.
- Frederick IO, Williams MA, Sales AE, et al. Pre-pregnancy body mass index, gestational weight gain, and other maternal characteristics in relation to infant birth weight. Matern Child Health J. 2008;12(5):557–567.
- Getahun D, Ananth CV, Peltier MR, et al. Changes in prepregnancy body mass index between the first and second pregnancies and risk of large-for-gestational-age birth. Am J Obstet Gynecol. 2007;196(6):530.e1–530.e8.
- González-Quintero VH, Istwan NB, Rhea DJ, et al. The impact of glycemic control on neonatal outcome in singleton pregnancies complicated by gestational diabetes. Diabetes Care. 2007;30(3):467–470.
- Kamanu CI, Onwere S, Chigbu B, et al. Fetal macrosomia in African women: a study of 249 cases. Arch Gynecol Obstet. 2009;279(6):857–861.
- Pontus BM, Jun W, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2013;481(4):463–468.
- Hernandez-Trejo M, Garcia-Rivas G, Torres-Quintanilla A, et al. Relationship between irisin concentration and serum cytokines in mother and newborn. PLOS One. 2016;11(11):e0165229.
- Ökdemir D, Hatipoğlu N, Kurtoğlu S, et al. The role of irisin, insulin and leptin in maternal and fetal interaction. J Clin Res Pediatr Endocrinol. 2018;10(4):307–315.
- Yan B, Shi X, Zhang H, et al. Association of serum irisin with metabolic syndrome in obese Chinese adults. PLOS One. 2014;9(4):e94235.
- Jedrychowski MP, Wrann CD, Paulo JA, et al. Detection and quantitation of circulating human irisin by tandem mass spectrometry. Cell Metab. 2015;22(4):734–740.
- Foda AA, Foda EA. Effects of delivery on maternal & neonatal irisin levels in normal and preeclamptic pregnant women. Pregn Hypertens. 2017;10:226–229.
- Stengel A, Hofmann T, Goebel-Stengel M, et al. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity – correlation with body mass index. Peptides. 2013;39(1):125–130.
- Ornoy A. Prenatal origin of obesity and their complications: gestational diabetes, maternal overweight and the paradoxical effects of fetal growth restriction and macrosomia. Reprod Toxicol. 2011;32(2):205–212.
- Briana DD, Malamitsi-Puchner A. The role of adipocytokines in fetal growth. Ann N Y Acad Sci. 2010;1205:82–87.
- Yu XD, Cao LL, Yu XG. Elevated cord serum manganese level is associated with a neonatal high ponderal index. Environ Res. 2013;121(2):79–83.
- Okah FA, Hoff G, Dew P, et al. Ponderal Index of the newborn: effect of smoking on the index of the small-for-gestational-age infant. Am J Perinatol. 2010;27(5):353–360.
- Baskett TF, Nagele F. Naegele’s rule: a reappraisal. BJOG. 2000;107(11):1433–1435.
- Palacios-González B, Vadillo-Ortega F, Polo-Oteyza E, et al. Irisin levels before and after physical activity among school-age children with different BMI: a direct relation with leptin. Obesity. 2015;23(4):729–732.
- Reinehr T, Elfers C, Lass N, et al. Irisin and its relation to insulin resistance and puberty in obese children: a longitudinal analysis. J Clin Endocrinol Metab. 2015;100(5):2123–2130.
- Keleş E, Turan FF. Evaluation of cord blood irisin levels in term newborns with small gestational age and appropriate gestational age. Springerplus. 2016;5(1):1757.
- Henriksen T. The macrosomic fetus: a challenge in current obstetrics. Acta Obstet Gynecol Scand. 2008;87(2):134–145.
- Ovesen P, Rasmussen S, Kesmodel U. Effect of prepregnancy maternal overweight and obesity on pregnancy outcome. Obstet Gynecol. 2011;118(2 Pt 1):305–312.
- Essel JK, Opai-Tetteh ET. Macrosomia: maternal and fetal risk factors. S Afr Med J. 1995;85(1):43–46.
- Vinturache AE, Chaput KH, Tough SC. Pre-pregnancy body mass index (BMI) and macrosomia in a Canadian Birth Cohort. J Mater-Fetal Neonatal Med. 2017;30(1):109–116.
- Joung KE, Park KH, Filippaios A, et al. Cord blood irisin levels are positively correlated with birth weight in newborn infants. Metab Clin Exp. 2015;64(11):1507–1514.
- Crujeiras AB, Zulet MA, Lopez-Legarrea P, et al. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. Metab Clin Exp. 2014;63(4):520–531.
- Blüher S, Panagiotou G, Petroff D, et al. Effects of a 1-year exercise and lifestyle intervention on irisin, adipokines, and inflammatory markers in obese children. Obesity. 2014;22(7):1701–1708.
- Huh JY, Panagiotou G, Mougios V, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012;61(12):1725–1738.
- Park KH, Zaichenko L, Brinkoetter M, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013;98(12):4899–4907.